Boston Scientific Corp (MIL:1BSX)
€ 85.5 0 (0%) Market Cap: 126.98 Bil Enterprise Value: 135.61 Bil PE Ratio: 74.26 PB Ratio: 6.39 GF Score: 56/100

Boston Scientific Corp at Stephens Investor Conference Transcript

Nov 14, 2019 / 09:15PM GMT
Christopher Cook Cooley
Stephens Inc., Research Division - MD

Well, good afternoon, everyone. I appreciate you joining us here at the latter afternoon sessions. I'm Chris Cooley. I'm the senior medical device analyst here at Stephens. And our last company, but arguably one of the most interesting companies we've got in our medical device and hospital supply track today, is Boston Scientific. And so we're honored to have Susie Lisa, who's Vice President and Director of Investor Relations for Boston Scientific with us here today.

Susie, thanks so much for joining us.

Susan Vissers Lisa
Boston Scientific Corporation - VP of IR

Thanks for having us, Chris.

Christopher Cook Cooley
Stephens Inc., Research Division - MD

We appreciate you being here in Nashville.

Questions & Answers

Christopher Cook Cooley
Stephens Inc., Research Division - MD

Let's just start off with -- when we think about the company here, you recently guided to 6% to 9% when we think

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot